// App-Quantinova.ai

OP0192 : PSORIATIC ARTHRITIS IS ASSOCIATED WITH A METABOLICALLY ADVERSE BODY COMPOSITION PROFILE PREDICTIVE OF GREATER CHD AND TYPE 2 DIABETES RISK – MRI FINDINGS FROM THE IMAPA AND UK BIOBANK STUDIES

Researchers

Presenter

  • L. D. Ferguson

Principal Investigators

  • J. Linge

  • O. D. Leinhard

  • I. Mcinnes

  • S. Siebert

  • N. Sattar

Medical Centers

  • University of Glasgow, Institute of Cardiovascular and Medical Sciences, Glasgow, United Kingdom

  • AMRA Medical AB, Linkoping, Sweden

  • University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom

Locations

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Psoriatic arthritis

  • Type 2 diabetes mellitus

  • Inflammatory Arthritis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bristol-Myer Squibb

Result

  • N/A